Jim Cramer
Our newest portfolio stock backed off its recent 52-week high — so we’re buying more
We’re buying 300 shares of Bristol-Myers Squibb at roughly $58 each. Following Wednesday’s trade, Jim Cramer’s Charitable Trust will own 900 shares of BMY, increasing its weighting to about 1.5% from 1%. Shares of pharmaceutical maker Bristol-Myers have dropped about 3% in the past two days in the absence of any real news. The stock […]
Read More
Jim Cramer’s big takeaway from the market reaction to Nvidia’s earnings beat
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Thursday’s key moments. 1. Wall Street is having a mixed session Thursday. While the Dow Jones Industrial Average was slightly higher, the S & P 500 and tech-heavy Nasdaq Composite gave up earlier […]
Read More
Jim Cramer wants to buy this falling tech stock — and touts another reason to like Disney
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. 1. Stocks were in the red Wednesday, led to the downside by the Nasdaq Composite. The tech-heavy index was weighed down by Nvidia slipping 2% ahead of its earnings after […]
Read More
2 health stocks are buys. They’ve been beaten up enough on Trump’s RFK Jr. pick for HHS
We are buying 25 shares of Danaher at roughly $229 each. Following Monday’s trade, Jim Cramer’s Charitable Trust will own 550 shares of DHR, increasing its weighting to roughly 3.6% from 3.4%. The health care sector has been the big loser in the market since the election. If the SPDR Health Care Sector Fund , […]
Read More
How we’re thinking about Eli Lilly after Trump picked obesity-drug critic RFK Jr. to run HHS
Enthusiasm for Club holding Eli Lilly needs to be tempered — at least for now — as Wall Street grapples with the possibility of a major shakeup to health policy in Washington. The news Republican President-elect Donald Trump on Thursday nominated prominent vaccine skeptic and obesity-drug critic Robert F. Kennedy Jr. to lead the Department […]
Read More
Jim Cramer’s top 10 things to watch in the stock market Friday
My top 10 things to watch Friday, Nov. 15 1. President-elect Donald Trump’s decision to nominate prominent vaccine skeptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services has vast implications for drug companies. That’s why shares of pharma stocks, and vaccine makers in particular, sold off late Thursday when reports […]
Read More
Here’s a rapid-fire update on what Trump will mean for all 33 portfolio stocks
Here’s a rapid-fire update on all the stocks in Jim Cramer’s Charitable Trust, the portfolio we use for the CNBC Investing Club. During the November Monthly Meeting on Thursday, Jim looked at how Donald Trump’s return to the White House could impact each company — good, bad or not much at all. Apple : If […]
Read More
What’s behind Salesforce’s record highs — plus, a possible stock to buy after this week’s earnings
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. 1. The S & P 500 edged higher Monday, extending Friday’s postelection all-time highs. The tech-heavy Nasdaq was basically flat. Club chip names Advanced Micro Devices , Broadcom , and […]
Read More
The 2 things that will drive the stock market after last week’s Trump-Fed rally
President Donald Trump looks on as his nominee for the chairman of the Federal Reserve Jerome Powell takes to the podium during a press event in the Rose Garden at the White House, November 2, 2017 in Washington, DC. Drew Angerer | Getty Images Talk about an eventful week. Normally, when the Fed cuts interest […]
Read More
Jim Cramer: Abbott stock is ‘dirt cheap’ after a surprising legal win validates our conviction
Abbott Laboratories shares jumped Friday after the Club holding picked up a surprise victory in a trial over the safety of its formula for premature babies. The news Abbott Labs’ specialized formula is not responsible for a young baby boy developing a severe intestinal illness known as necrotizing enterocolitis, or NEC, a jury in Missouri […]
Read More